文献一覧: 03727629 (ISSN) - Ceek.jp Altmetrics

2 0 0 0 OA 日本に必要な薬がない?

著者: 後藤伸之
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.63, no.4, pp.197-200, 2003 (Released:2019-05-12)
参考文献数: 11

2022-02-07 01:11:23
2 + 1 Twitter

2 0 0 0 OA 抗体医薬品の溶液物性

著者: 内山進エレナクラユヒナ野田勝紀
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.74, no.1, pp.12-18, 2014 (Released:2014-07-01)
参考文献数: 10
被引用文献数: 2

2021-10-01 09:01:33
2 + 4 Twitter

2 0 0 0 薬剤師は医薬品の生物学的同等性の番人である : 薬が先で, 簡易懸濁法が先ではない

著者: 永井恒司
雑誌: 薬剤学 = The archives of practical pharmacy (ISSN:03727629)
巻号頁・発行日: vol.69, no.3, pp.217-218, 2009-05-01
被引用文献数: 1

2021-06-25 15:00:34
2 + 0 Twitter

https://ci.nii.ac.jp/naid/10025720581

2 0 0 0 OA 調剤過誤防止のための「処方せん」

著者: 坂本真史
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.76, no.3, pp.127-130, 2016 (Released:2016-11-01)
参考文献数: 3

2020-09-22 14:53:22
2 + 1 Twitter

2 0 0 0 OA 新しい学校薬剤師の役割 ―アメリカでの薬物乱用防止教育を中心に―

著者: 山﨑健
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.66, no.5, pp.323-325, 2006 (Released:2019-04-13)
参考文献数: 1

2020-08-07 08:00:11
2 + 0 Twitter

2 0 0 0 OA アダパレンゲル(ディフェリンゲル)の配合変化

著者: 大谷道輝山岡由紗松元美香並木路広山村喜一江藤隆史
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.69, no.6, pp.470-476, 2009 (Released:2019-03-31)
参考文献数: 14

Topical retinoids are very important in acne treatments. Clinical experience has shown that adapalene, a new topical retinoid, has a superior cutaneous safety profile. In the guidelines of care for acne vulgaris management of our country, the combinations with adapalene gel and topical antibiotics (e.g., clindamycin nadifloxacin) are an effective acne treatment, and these combination treatments are ranked as a recommendation A. For the purpose of improvement of compliance, the mixing of ointments and/or creams is common practice. However, many of the admixtures of ointments and/or creams may lack pharmaceutical stability.To assess the pharmaceutical stability of these mixtures after mixing, we attempted to investigate the change in the appearance and contents of adapalene, clindamycin and nadifloxacin in admixtures. As a result, no lowering of the content of adapalene was noted in any admixtute. After admixtures of adapalene and clindamycin or nadifloxacin, the contents of clindamycin or nadifloxacin were constant.

2020-07-25 18:27:10
2 + 3 Twitter

2 0 0 0 OA 薬剤師と院内製剤を取り巻く環境の変化~過去,現在,未来~

著者: 花輪剛久藤井まき子近藤直樹国忠聡花輪正明
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.80, no.1, pp.24-35, 2020 (Released:2020-01-01)

2020-07-01 23:00:20
2 + 5 Twitter

2 0 0 0 OA 処方せん記載様式の変更について

著者: 山本信夫
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.71, no.2, pp.78-81, 2011 (Released:2019-03-02)

2020-04-30 00:33:30
2 + 2 Twitter

2 0 0 0 OA 癌化学療法時の口腔粘膜障害予防を目的としたメシル酸カモスタットトローチ剤の開発

著者: 郡修徳小澤武史高崎雅彦江口久恵三輪興三沼潤幸阿部信
出版者: 公益社団法人日本薬剤学会
雑誌: 薬剤学 (ISSN:03727629)
巻号頁・発行日: vol.61, no.1, pp.34-45, 2001 (Released:2019-05-18)
参考文献数: 19

We prepared a troche containing camostat mesilate for the prevention of the mucositis in the mouth induced by cancer chemotherapy. The troche was formed by the direct compression of a powder mixture of camostat mesilate, a flavoring agent, hydroxypropylcellulose, and magnesium stearate. A troche containing 10% or 20% hydroxypropylcellulose and a flavoring agent of coffee or green apple diminished the bitterness of camostat mesilate. It was found that the metabolising rate of camostat in saliva was much slower than that in blood, although metabolites in saliva were the same kinds as those in blood. The amounts of camostat retained in the mouth after administration of the troche to healthy subjects were much larger than those after applying a gargle which had a bitter taste. Moreover, the troche containing the flavoring agent of green apple showed smaller amounts of camostat and its metabolites retained in the mouth compared to the troche containing the flavoring agent of coffee. It is considered that the increase in the secreting volume of saliva after administration of the troche containing the flavoring agent of green apple would prevent the retaining of camostat and its metabolites in the mouth. Moreover, the administration of a troche is more convenient than that of a gargle for patients. The troche prepared in this study would be a substitute dosage form for the gargle and promote the quality of life in patients.